Rentschler Biopharma has announced its appointment of Veit Bergendahl, PhD, as Chief Operating Officer (COO). Bergendahl succeeds Christiane Bardroff, who will depart Rentschler in the first quarter of 2026 after three-and-a-half years as COO. Effective April 1, Bergendahl assumes responsibility for Rentschler’s operational areas of clinical and commercial current good manufacturing practice (cGMP) manufacturing). He will also oversee cGMP engineering and technology, in addition to production...